CEBPZ and acute myeloid leukemia: GO + FLAG (Fludarabine 30 mg/m2/day, on days 1–5, Ara-C 2 g/m2/day, on days 1–5, GO 3 mg/m2/day on day 1, and G-CSF 3 mg/kg/day) also studied in relapsed/refractory AML reported excellent clinical and molecular response in 29 of the 34 young adults with CBF-AML [59].